Unlock Full Company Report
Access verified contacts, investors & buying signals.
Recently Funded|Amount: EUR 2.0M|Industry: Technology, Information and Internet
Breaking News: Dylogy Secures $2 Million in Pre-Seed Round Funding for Innovative AI Document Management Platform!
Dylogy

View Full Report
Includes contacts, investors & buying signals
In an exciting development for the insurtech landscape, French startup Dylogy has successfully raised €2 million in its latest funding round. Founded in 2023, the company—formerly known as Novaa Tech—was established by a trio of innovative engineers and actuaries from the insurance and technology sectors. Dylogy specializes in empowering insurers, reinsurers, and brokers with cutting-edge generative AI technology, enabling them to manage their documents and associated risks more efficiently. The unique platform developed by Dylogy is designed to process and analyze a wide array of documents, offering critical insights that facilitate informed decision-making and proactive risk monitoring. As a testament to its potential, Dylogy was recognized as a French Tech Seed startup in 2024, and it also received the French Tech Emergence grant from the Pouss@LYS consortium, reflecting the company’s dedication to advancing the Deeptech field. The newly acquired funding will be instrumental in accelerating the development of Dylogy’s proprietary platform, enhancing its features and broadening its user base. With this financial support, the company aims to further its mission of transforming the insurance sector through innovative technology, ultimately creating a more fluid and responsive approach to document management and risk assessment. As Dylogy continues to make strides in the industry, the startup is poised for impactful growth and collaboration in the years to come.
Buying Signals & Intent
Our AI suggests Dylogy may be interested in solutions related to:
- AI Software
- Document Processing Solutions
- Risk Analysis Tools
- Insurance Analysis Software
- Compliance Management Systems
Sell these products?
Unlock full report to find contacts.
Investors
Unlock Investor Data
See who invested in Dylogy and potentially find related investment contacts.
Unlock Premium AccessKey Decision Makers
Unlock Verified Contacts
Get direct email addresses and phone numbers for key decision makers at Dylogy.
Unlock Contacts Now